Latest Lamotrigine Stories
WALTHAM, Mass., Dec.
The cause of autism remains a mystery to the medical community, but researchers have found a link between an epilepsy drug and an increased risk of a child developing autism.A new study shows women who take the epilepsy drug valproate while pregnant may significantly increase their unborn baby's risk of developing autism.In an ongoing study conducted by the Liverpool and Manchester Neurodevelopment Group, researchers are examining 632 children, about half of whom were exposed to epilepsy...
Prenatal exposure to the epilepsy drug valproate may increase a child's risk of autism, a British researcher says.
GlaxoSmithKline has announced that it will close its manufacturing site in Dartford. Following the conclusion of a recent review of activities at its manufacturing site in Dartford, the company proposes to close the facility and transfer production to alternative facilities.
WALTHAM, Mass., Aug. 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that an astonishing 52.3 percent of newly diagnosed bipolar disorder patients are prescribed antidepressant drugs first line.
Lupin Pharmaceuticals has received final approval for its abbreviated new drug application for divalproex sodium delayed-release tablets, 125mg, 250mg and 500mg from the FDA. Commercial shipments of the product have already commenced.
The FDA is close to adding a black box warning to epilepsy drugs after a safety review showed that they increase patients' risk of suicidal thoughts and behavior.
By Anthony J. Brown, MD NEW YORK (Reuters Health)
Cephalon Inc.'s experimental drug to treat attention deficit hyperactivity disorder may have fallen victim more to the timing of its audition than the quality of its performance, some experts say.
- A political dynamiter.